EMEA-003156-PIP01-21
Submitted by Anonymous (not verified) on 27 November 2025 - 14:02
EMEA-003156-PIP01-21
EMEA-002284-PIP01-17
Submitted by Anonymous (not verified) on 27 November 2025 - 14:00
EMEA-002284-PIP01-17
Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Date of authorisation: 23/02/2001, Revision: 24, Status: Authorised
Submitted by Anonymous (not verified) on 27 November 2025 - 13:30
Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Date of authorisation: 23/02/2001, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation: 17/11/2025, Status: Authorised
Submitted by Anonymous (not verified) on 27 November 2025 - 13:20
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation: 17/11/2025, Status: Authorised
Withdrawn application: Brilique, 15/12/2021
Submitted by Anonymous (not verified) on 27 November 2025 - 12:42
Withdrawn application: Brilique, 15/12/2021
Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Date of authorisation: 23/05/2018, Revision: 18, Status: Authorised
Submitted by Anonymous (not verified) on 27 November 2025 - 11:25
Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Date of authorisation: 23/05/2018, Revision: 18, Status: Authorised
Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee
Submitted by Anonymous (not verified) on 27 November 2025 - 11:16
Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee
Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Lapsed
Submitted by Anonymous (not verified) on 27 November 2025 - 10:45
Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Lapsed
PSUSA/00000843/202501
Submitted by Anonymous (not verified) on 27 November 2025 - 8:57
PSUSA/00000843/202501
Medicines authorised during pandemic
Submitted by Anonymous (not verified) on 26 November 2025 - 15:38
Medicines authorised during pandemic